Proteomic Insights Into Moxifloxacin Efficacy and Resistance in Vibrio parahaemolyticus
PROTEOMICS · 10.07.2026
DOI: 10.1002/pmic.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 10.07.2026. Verfasst von Zhen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhangzhou Health Vocational College, Zhangzhou, China. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Zhangzhou Science and Technology Bureau, Research Support Project for Highly Educated Talents at Zhangzhou Health Vocational College, Foreign Cooperation Project of Fujian Science and Technology Department.
Abstract (Originalsprache)
The emergence of multidrug‐resistant Vibrio parahaemolyticus poses major public health challenges, necessitating new treatment strategies. This research uses quantitative proteomics to explore the underlying antibiotic stress response mechanisms of moxifloxacin (Mox), a broad‐spectrum fluoroquinolone, which effectively targets clinically resistant strains. After exposing bacteria to 1/2 MIC of Mox (2.5 ng/ml), proteomic analysis revealed significant changes in differentially expressed proteins (DEPs). These DEPs were enriched in several gene ontology (GO) and KEGG pathways, including SOS responses, cellular response to external stimuli, DNA helicase complexes, and transmembrane transport. KEGG analysis also indicated involvement in alanine, aspartate, and glutamate metabolism. PPI analysis revealed that many DEPs participated in quorum sensing (VP0047, VP0048, VP2088, VP0050, VP0049, and VP2091 downregulated), amino acid metabolism (VP1772, VP0483, VP0481, VP0826, ArgH, VP0484 downregulated, while CarA and CarB were upregulated), and kinase activity (VP0364, VP0365, VP0366, VP1190 downregulated; VP0370, VP1688, VPA0094, VPA0095, MltD, and Flg2 upregulated). Under Mox treatment, V. parahaemolyticus increased production of fluoroquinolone resistance proteins (VP1315 and VPA0095) and multidrug efflux components (VPA1190 and VPA1191), shifting from efflux‐based resistance toward DNA repair mechanisms that maintain genome stability under fluoroquinolone stress. These proteomic findings confirm the primary bactericidal effect of Mox and reveal stress responses that could precede stress response. Overall, this profiling offers insights for optimizing fluoroquinolone therapy and developing additional treatments to combat resistance in V. parahaemolyticus infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhangzhou Health Vocational College, Zhangzhou, China.
- School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
- Key Laboratory of Marine Biotechnology of Fujian Province, Institute of Oceanology, Fujian Agriculture and Forestry University, Fuzhou, China.
- The Third Affiliated Hospital of Nanchang University (also known as the First Hospital of Nanchang), Nanchang, China.
- Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Förderung
- Zhangzhou Science and Technology Bureau
- Research Support Project for Highly Educated Talents at Zhangzhou Health Vocational College
- Foreign Cooperation Project of Fujian Science and Technology Department
- Natural Science Foundation of Zhangzhou
- Key Laboratory of Marine Biotechnology of Fujian Province
- The 2024 Research Special Project of the National Vocational Education Teacher Innovation Team in Chinese Pharmacy
- Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop
Zitieren
APA
Li, Z., Chen, X., Jia, C., Liu, Y., Lian, L., Lin, X., Li, L., & Ali, F. (2026). Proteomic Insights Into Moxifloxacin Efficacy and Resistance in Vibrio parahaemolyticus. PROTEOMICS. https://doi.org/10.1002/pmic.70156
Vancouver
Li Z, Chen X, Jia C, Liu Y, Lian L, Lin X, et al. Proteomic Insights Into Moxifloxacin Efficacy and Resistance in Vibrio parahaemolyticus. PROTEOMICS. 2026. doi:10.1002/pmic.70156
BibTeX
@article{Li2026,
author = {Li, Zhen and Chen, Xin and Jia, Chunyan and Liu, Yankai and Lian, Lingli and Lin, Xiangmin and Li, Liping and Ali, Farman},
title = {Proteomic Insights Into Moxifloxacin Efficacy and Resistance in Vibrio parahaemolyticus},
journal = {PROTEOMICS},
year = {2026},
doi = {10.1002/pmic.70156}
}
EUVIMED